Asia-Pacific Americas Africa Europe Middle East

SIMSON PHARMA LIMITED Индия

Company Profile:

SIMSON PHARMA LIMITED India Company Introduction:

SIMSON PHARMA LIMITED is a pharmaceutical company based in India. It specializes in the manufacturing and exporting of a diverse range of pharmaceutical formulations. The company produces various dosage forms such as tablets, capsules, oral liquids, dry syrups, injections, and ointments. SIMSON PHARMA LIMITED is committed to providing quality and affordable healthcare products to both domestic and international markets.

SIMSON PHARMA LIMITED is a Factory.

Enterprise Products

SIMSON PHARMA LIMITED, India, manufactures and sells Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. Their product portfolio encompasses a wide range of APIs used in various therapeutic areas.

Some of their key Active Pharmaceutical Ingredients include:

Dapoxetine Hydrochloride, Dutasteride, Finasteride, Minoxidil, Sildenafil Citrate, Tadalafil, Vardenafil Hydrochloride, Avanafil, Flibanserin, Ruxolitinib, Lurasidone Hydrochloride, Apixaban, Sacubitril, Valganciclovir, Sofosbuvir, Ledipasvir, Velpatasvir, Daclatasvir, Entecavir, Tenofovir Disoproxil Fumarate, Abiraterone Acetate, Enzalutamide, Palbociclib, Ibrutinib, Acalabrutinib, Osimertinib, Brigatinib, Neratinib, Lorlatinib, Pomalidomide, Lenalidomide, Ixazomib Citrate, Carfilzomib, Bortezomib, Cabozantinib, Regorafenib, Sorafenib, Axitinib, Sunitinib Malate, Pazopanib Hydrochloride, Lenvatinib Mesylate, Nintedanib Esylate, Crizotinib, Ceritinib, Alectinib Hydrochloride, Erlotinib Hydrochloride, Afatinib Dimaleate, Gefitinib, Lapatinib Ditosylate, Everolimus, Sirolimus, Temsirolimus, Midostaurin, Gilteritinib Fumarate, Venetoclax, Glasdegib Maleate, Sonidegib Phosphate, Vismodegib, Tofacitinib Citrate, Baricitinib, Upadacitinib, Filgotinib, Peficitinib, Ozanimod Hydrochloride, Siponimod Fumarate, Ponesimod, Fingolimod Hydrochloride, Teriflunomide, Dimethyl Fumarate, Cladribine, Glatiramer Acetate, Interferon Beta-1a, Interferon Beta-1b, Peginterferon Beta-1a, Fampridine, and Dalfampridine, among many others.

They also provide pharmaceutical intermediates essential for the synthesis of these APIs.

Business Registration Information:

Manager:

Mr. Jigar Shah (Managing Director)

Phone:

+91 22 4005 3333, +91 22 2887 0707

E-mail:

info@simsonpharma.com, sales@simsonpharma.com

Official Website:
Address:

A-304, Gundecha Industrial Complex, Akurli Road, Kandivali (E), Mumbai - 400101, Maharashtra, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.